Nodal Nevi vs. Metastatic Melanoma: Breast Cancer Case Report
When Benign Looks Like Cancer: The Diagnostic Challenge of Nodal Nevi
Table of Contents
Published August 22, 2025
The Mimicry of Melanoma: A Growing Concern
Distinguishing between metastatic melanoma and benign clusters of melanocytic nevus cells (moles) within lymph nodes can be surprisingly difficult, even for experienced pathologists. This challenge is becoming increasingly relevant as sentinel lymph node biopsies become more common, particularly in cancer treatment. A recent case highlights the complexities that can arise, especially when evaluating lymph nodes after neoadjuvant therapy – treatment given *before* surgery – for breast cancer.
The difficulty stems from the fact that benign nevi can sometimes exhibit growth patterns that closely resemble those of melanoma, raising concerns about a false positive diagnosis.This is particularly true when the nodes have been affected by prior treatment.
Why Accurate Diagnosis Matters
The presence or absence of melanoma in sentinel lymph nodes is a critical factor in determining a patient’s cancer stage, prognosis, and treatment plan. an incorrect diagnosis can lead to unneeded surgery or systemic therapies, while a missed diagnosis can delay crucial treatment.As stated in research, sentinel lymph node status is a key driver of melanoma staging, prognosis, and treatment decisions (MD Anderson Cancer Center).
Understanding Nodal Nevi
melanocytic nevi within lymph nodes – ofen called nodal nevi – are a recognized phenomenon. Thay are essentially moles that have migrated to the lymph nodes. Research indicates that these nevi are an critically important consideration when evaluating sentinel lymph nodes for potential melanoma spread (PMC – National Center for Biotechnology Information).The frequency of identifying these nevi has increased alongside the increased use of sentinel lymph node biopsies for various cancers, not just melanoma (ScienceDirect).
There isn’t a single “type” of nodal nevus, but recent studies have begun to categorize them to aid in differentiation from melanoma. These classifications help pathologists better assess the risk of misdiagnosis.
The Case of the Axillary Lymph Node
A recent case involved a patient undergoing neoadjuvant therapy for breast cancer. During evaluation of the axillary lymph nodes (lymph nodes under the arm), a cluster of cells was identified that initially raised suspicion for metastatic melanoma.However, further examination revealed the cells to be a benign melanocytic nevus. This case underscores the importance of careful pathological examination and consideration of the patient’s clinical history,including prior treatments.
What Does This Mean for Patients?
If you are undergoing cancer treatment and have a sentinel lymph node biopsy, it’s important to understand that there is a possibility of encountering this diagnostic challenge. Don’t hesitate to ask your oncologist and pathologist about the findings and the steps they are taking to ensure an accurate diagnosis. A second opinion might potentially be warranted in complex cases.
